Search research articles
Contact Us
Filters
Showing results (31-40 of 34) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 34 results.
Lancet (London, England)
|
September 6, 2000
Relation between food provocation and systemic immune activation in patients with food intolerance
M B Jacobsen, P Aukrust, E Kittang, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 10, 1999
Expression of p68 protein kinase and its prognostic significance during IFN-alpha therapy in patients with carcinoid tumours
Y Zhou, A Gobl, S Wang, et al.
Lancet (London, England)
|
February 11, 1995
Subcutaneous immunoglobulin replacement in patients with primary antibody deficiencies: safety and costs
A Gardulf, V Andersen, J Björkander, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 24, 1999
Efficacy and safety of prolonged-release lanreotide in patients with gastrointestinal neuroendocrine tumors and hormone-related symptoms
A N Wymenga, B Eriksson, P I Salmela, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 34) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 34 results.
Lancet (London, England)
|
September 6, 2000
Relation between food provocation and systemic immune activation in patients with food intolerance
M B Jacobsen, P Aukrust, E Kittang, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 10, 1999
Expression of p68 protein kinase and its prognostic significance during IFN-alpha therapy in patients with carcinoid tumours
Y Zhou, A Gobl, S Wang, et al.
Lancet (London, England)
|
February 11, 1995
Subcutaneous immunoglobulin replacement in patients with primary antibody deficiencies: safety and costs
A Gardulf, V Andersen, J Björkander, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 24, 1999
Efficacy and safety of prolonged-release lanreotide in patients with gastrointestinal neuroendocrine tumors and hormone-related symptoms
A N Wymenga, B Eriksson, P I Salmela, et al.
Page
of 4